Brief news reports on Tuberculosis

Reducing the burden of TB treatment

Tuberculosis is one of the world's deadliest infectious diseases: One-third of the world's population is infected with TB, and more than 1 million people die from the disease every year.

Read More →

ECDC-WHO report: TB surveillance and monitoring in Europe 2019

Every hour 30 people are diagnosed with TB in the European Region. It’s time to make TB a disease of the past.

Read More →

Final STREAM Stage 1 trial results published

The final results from the STREAM Stage 1 trial, which compared 9-11 months of standardized treatment using older drugs (the so-called modified "Bangladesh" regimen) to the 2011 World Health Organization (WHO)-recommended treatment, were published in the New England Journal of Medicine.

Read More →

Research demonstrates how immunotherapy may be effective for fighting TB

In part because of its resistance to many antibiotics, tuberculosis kills approximately 1.7 million people worldwide each year. But new research from the University of Notre Dame suggests that structures released by the infected cells may be used in tandem with antibiotics to boost the body’s immune system, helping fight off the disease.

Read More →

WHO’s revamped Civil Society Task Force determines priority actions to end TB

The World Health Organization’s (WHO) revamped Civil Society Task Force on TB (CSTF) held its first meeting on 7-8 March to identify key priorities for the period 2019-2020.

Read More →

Lab in South African “township” to sample TB from breathed air

A new facility located in a congested community with high tuberculosis rates brings basic science and cutting edge techniques into the heart of disease circulation.

Read More →

CROI 2019: Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity

Adjusted doses of darunavir/ritonavir (DRV/r) with rifampicin (RIF) were associated with unacceptable risk of hepatotoxicity and a reduction in DRV trough concentrations in a pharmacokinetic (PK) study, conducted in South Africa, presented at CROI 2019.  

Read More →

TB CAB statement on safety of using bedaquiline and delamanid together

Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.

Read More →

TAG statement on FDA priority review of pretomanid

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.

Read More →

IT'S TIME to put women and girls at the center of TB response

On International Women's Day, 8 March 2019, the Stop TB Partnership reiterated the importance of putting women and girls at the center of the TB response.

Read More →

Page 2 of 638 · Total posts: 10

←First 1 2 3 Last→